Table 3.
Bivariate and multivariate association between the change in the initial cancer plan because of GA results.
| Variable |
Bivariate |
Multivariate |
||||
|---|---|---|---|---|---|---|
| General Characteristics | OR | 95% CI | P value | OR | 95% CI | P value |
| Age | ||||||
| 65–69 | 0.722 | 0.253–2.058 | 0.542 | |||
| 70–74 | 0.480 | 0.147–1.566 | 0.224 | |||
| 75–79 | 1.702 | 0.598–4.841 | 0.319 | |||
| 80–84 | 2.610 | 0.758–8.987 | 0.128 | |||
| 85+ | 0.000 | 0.000 | 0.999 | |||
| T1 | 1.103 | 0.427–2.852 | 0.840 | |||
| T2-4 | 0.907 | 0.351–2.345 | 0.840 | |||
| Node positive | 0.576 | 0.152–2.179 | 0.416 | |||
| LVI | 1.166 | 0.737–1.844 | 0.512 | |||
| Instrumental Activities of Daily Living (IADL) | 2.726 | 0.991–7.497 | 0.052 | |||
| Medical Outcomes Study (MOS) Activities of Daily Living (ADL) | 6.809 | 1.487–31.173 | 0.013* | |||
| Karnofsky Performance Status Scale | 3.865 | 1.354–11.032 | 0.012* | 2.566 | 0.830–7.930 | 0.102 |
| Comorbidity: Physical Health Section (Older American Resources & Services Questionnaire | 1.888 | 0.713–5.003 | 0.201 | |||
| Polypharmacy (3 or more medications) n (%) | 7.174 | 1.568–32.826 | 0.011* | 4.973 | 1.044–23.692 | 0.044* |
| Number of falls in last 6 months n (%) | 3.289 | 0.801–13.499 | 0.098 | |||
| Unintentional weight loss n (%) | 1.624 | 0.383–6.881 | 0.510 | |||
| BMI (30 or more) n (%) | 2.880 | 1.042–7.962 | 0.041* | |||
| Psychological Status: Mental Health Inventory (MHI)-17 | 0.893 | 0.095–8.421 | 0.921 | |||
| Social Functioning: Medical Outcomes Study (MOS) Social Activity Limitations Measure | 1.912 | 0.714–5.123 | 0.197 | |||
| Social Support: Medical Outcomes Study (MOS) Social Support Survey | 7.451 | 1.622–34.235 | 0.010* | 3.995 | 0.813–19.628 | 0.088 |
| Depression n (%) | 1.158 | 0.371–3.614 | 0.800 | |||
| Timed Up and Go (sec) | 1.247 | 0.322–4.837 | 0.749 | |||
| Blessed Orientation-Memory-Concentration Test | 0.000 | 0.000 | 0.999 | |||